SCHEMBL6987204

SCHEMBL6987204

[c]1cccc(C2CCNCC2)c1CN1CCCC1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 8/20 0.40
CXCR4 P61073 4/20 0.37
SLC6A2 P23975 3/20 0.36
SLC6A4 P31645 3/20 0.36
SLC6A3 Q01959 3/20 0.36
HTR1A P08908 2/20 0.36
PLAT P00750 1/20 0.36
MEN1 O00255 1/20 0.35
CHRM2 P08172 1/20 0.35
CHRM1 P11229 1/20 0.35
ADRA2C P18825 1/20 0.35
CCR2 P41597 1/20 0.35
CXCL12 P48061 1/20 0.35
BLM P54132 1/20 0.35
KMT2A Q03164 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
HRH3 Q9Y5N1 1/20 0.35
ADRA1D P25100 1/20 0.34
SIGMAR1 Q99720 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4830013 0.74 SLC6A2 (0.50) HTR2CSLC6A2SLC6A4SLC6A3HTR1A
SCHEMBL6325639 0.74 HTR2C (0.39) HTR2CSLC6A2SLC6A4SLC6A3HTR1A
SCHEMBL6329433 0.74 PRMT5 (0.43) HTR2CCXCR4SLC6A2SLC6A4SLC6A3
SCHEMBL6324444 0.74 HTR2C (0.39) HTR2CSLC6A2SLC6A4SLC6A3HTR1A
SCHEMBL14938797 0.69 ALDH1A1 (0.42) KMT2ATDP1HRH3
SCHEMBL7839191 0.69 HTR2C (0.45) HTR2CSLC6A2SLC6A4SLC6A3HTR1A
SCHEMBL1855361 0.69 LMNA (0.55) CXCR4MEN1CHRM2CHRM1ADRA2C
Hydrochloric Acid SCHEMBL19284685 0.68 CRHBP (0.47) HTR2CMEN1KMT2AADRA1D
SCHEMBL2173660 0.67 LMNA (0.49) HTR2CCXCR4SLC6A2SLC6A4HTR1A
SCHEMBL28079662 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1337251-A1 MONOCYCLIC OR BICYCLIC CARBOCYCLES AND HETEROCYCLES AS FACTOR XA INHIBITORS Bristol-Myers Squibb Pharma Company (US) 2003-08-27 EP disclosed
WO-2002102380-A1 MONOCYCLIC OR BICYCLIC CARBOCYCLES AND HETEROCYCLES AS FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2002-12-27 WO disclosed